Last reviewed · How we verify

NCT07261124

Effect of Health Promotion Model-Based Oculomotor Exercise Program on Sleep Quality in Older Adults

Not yet recruiting NA Last updated 3 December 2025
What this trial tests

NA trial testing Oculomotor Exercise Program in Sleep Quality in 68 participants. Not yet recruiting.

Timeline
5 January 2026
Primary endpoint
15 December 2026
30 December 2026

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment68
Start date5 January 2026
Primary completion15 December 2026
Estimated completion30 December 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

65 and older, any sex, with Sleep Quality or Older Adults (65 Years and Older). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to investigate the effect of a Health Promotion Model-based oculomotor exercise program on sleep quality among older adults living in a nursing home. The main questions it aims to answer are: Does the Health Promotion Model-based oculomotor exercise program improve sleep quality in older adults living in a nursing home? Does participation in the program enhance self-efficacy and promote better health behaviors related to sleep?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Quality

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07261124.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing